Exploring Promising Breakthroughs in Alzheimer’s Research

Join Ken Blaker, a health care and technology consultant, and Cuong Do, a health care executive, in an enlightening discussion on the latest breakthroughs in Alzheimer's research. They delve into recent milestones, including the FDA approval of Leqembi, as well as promising developments in anti-neuroinflammation drugs and genetic approaches. These cutting-edge strategies hold the potential to redefine the future of Alzheimer's care. Ken Blaker, an accomplished author, specializes in medical devices and FDA compliance, contributing to diverse fields like neurodegenerative disease treatments, cancer research, and addressing the opioid epidemic. Cuong Do, a seasoned health care executive, adds valuable insights to the conversation.